ReviewTranslational behavioral medicine2021
Emerging digital technologies in cancer treatment, prevention, and control.
Review in Translational behavioral medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
17 citing papers in PubMed, 2 syntheses or guidelines pooled it.
- Using digital technology to support wellbeing and independence among people living with incurable cancers: a systematic review.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2025Pooled it
- Rapid systematic review on developing web-based interventions to support people affected by cancer.BMJ open · 2022Pooled it
- Design and evaluation of a colon cancer mobile application.BMC gastroenterology · 2024Trial
- Method to engage invested partners to co-create feasible and sustainable approaches to design and implement cancer prevention and control tools.Research involvement and engagement · 2026Article
- Bangkok declarations on cancer control in Asia.The Lancet regional health. Western Pacific · 2025Review
- Transforming women's health, empowerment, and gender equality with digital health: evidence-based policy and practice.The Lancet. Digital health · 2025Review
- Patient and Provider Perspectives of a Web-Based Intervention to Support Symptom Management After Radioactive Iodine Treatment for Differentiated Thyroid Cancer: Qualitative Study.JMIR formative research · 2025Article
- Investigation and analysis of the status of cancer health popularization in China, 2023.World journal of clinical oncology · 2024Article
- Increasing Colorectal Cancer Screening Among Black Men in Virginia: Development of an mHealth Intervention.JMIR formative research · 2024Article
- Determinants of the implementation of eHealth-based long-term follow-up care for young cancer survivors: a qualitative study.BMC cancer · 2024Article
- Implementation of Health IT for Cancer Screening in US Primary Care: Scoping Review.JMIR cancer · 2024Article
- Quality assessment of mobile applications on postpartum hemorrhage management.Revista da Escola de Enfermagem da U S P · 2024Article
- Digital Health Technology & Cancer Care: Conceptual Framework Leading Comprehensive Fruitfulness.Journal of healthcare leadership · 2024Article
- Development and Promotion of an mHealth App for Adolescents Based on the European Code Against Cancer: Retrospective Cohort Study.JMIR cancer · 2023Article
- Applications of digital Medicine in oncology: Prospects and challenges.Cancer innovation · 2022Review
- Expanding access to cancer peer support: development of a website to deliver written peer support that meets patients' individual emotional and informational needs while reducing potential harms.Procedia computer science · 2022Article
- Behavioral medicine, cancer control, and NCI: reflections on a fruitful past and auspicious future.Translational behavioral medicine · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The very first issue of the journal of Translational Behavioral Medicine (TBM) was dedicated, in part, to the theme of Health Information Technology as a platform for evidence implementation. The topic was timely: legislation in the USA was passed with the intent of stimulating the adoption of electronic health records; mobile smartphones, tablets, and other devices were gaining traction in the consumer market, while members within the Society of Behavioral Medicine were gaining scientific understanding on how to use these tools to effect healthy behavior change. For the anniversary issue of TBM, we evaluated the progress and problems associated with deploying digital health technologies to support cancer treatment, prevention, and control over the last decade. We conducted a narrative review of published literature to identify the role that emerging digital technologies may take in achieving national and international objectives in the decade to come. We tracked our evaluation of the literature across three phases in the cancer control continuum: (a) prevention, (b) early detection/screening, and (c) treatment/survivorship. From our targeted review and analyses, we noted that significant progress had been made in the adoption of digital health technologies in the cancer space over the past decade but that significant work remains to be done to integrate these technologies effectively into the cancer control systems needed to improve outcomes equitably across populations. The challenge for the next 10 years is inherently translational.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.